Bruker reports 20.5% increase in revenue for first-quarter 2010

NewsGuard 100/100 Score

Bruker Corporation (NASDAQ: BRKR) today reported financial results for the first quarter ended March 31, 2010.

Financial Results

In the first quarter of 2010, Bruker's revenue was $277.7 million, an increase of 20.5% compared to revenue of $230.5 in the first quarter of 2009. Excluding the effects of foreign currency translation, first quarter 2010 revenue increased by 12.4% year-over-year. In the first quarter of 2010, GAAP revenue increased by 16.4% year-over-year for the Bruker Scientific Instruments (BSI) segment, and by 156% year-over-year for the Bruker Energy & Supercon Technologies (BEST) segment.

Bruker's operating income in the first quarter of 2010 was $26.9 million, compared to $14.3 million in the first quarter of 2009. GAAP operating margin for the BSI segment in the first quarter of 2010 was 10.6%, compared to 7.2% in the first quarter of 2009.

Bruker's GAAP net income for the first quarter of 2010 was $16.1 million, or $0.10 per diluted share, compared to net income of $8.4 million, or $0.05 per diluted share, in the first quarter of 2009. Included in Bruker's earnings per share (EPS) for the first quarter 2010 was non-cash stock-based compensation expense of ($0.01) per diluted share, the same as in the first quarter of 2009. EPS for the BSI segment in the first quarter of 2010 was $0.10, compared to $0.06 in the first quarter of 2009. EPS for the first quarter of 2010 for the BEST segment was $0.00, compared to a loss of ($0.02) in the first quarter of 2009.

Bruker cash flow from operations for the first quarter 2010 was $5.5 million, compared to $13.1 million in the first quarter of 2009. Bruker ended the first quarter of 2010 with cash, cash equivalents and restricted cash of $206.6 million, and net cash of $73.4 million.

Comment and Outlook

Frank Laukien, President and CEO, commented: "We are very pleased with our first quarter 2010 results, with strong year-over-year revenue growth and significant improvements in gross and operating margins. All four operating divisions in our BSI segment delivered double-digit growth year-over-year, and our BEST segment had triple-digit growth for the second quarter in a row. The industrial and applied markets continued to improve gradually during the first quarter, and overall we recorded healthy new order bookings, including more than $10 million in additional U.S. stimulus orders, all of which contributed to strong backlog at the end of the first quarter."

SOURCE Bruker Corporation

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A step forward in vaccine technology: Exploring the effects of N1-methylpseudouridine in mRNA translation